Advances in Study on DCF Regimen in Treatment of Advanced Gastric Cancer / 胃肠病学
Chinese Journal of Gastroenterology
; (12): 756-759, 2017.
Article
en Zh
| WPRIM
| ID: wpr-665016
Biblioteca responsable:
WPRO
ABSTRACT
Gastric cancer is one of the most common malignancies and chemotherapy is the main method for the treatment of advanced gastric cancer. Chemotherapy can improve the quality of life and prolong the survival time of patients with advanced or metastatic gastric cancer. The DCF regimen (docetaxel,cisplatin and 5-fluorouracil)is effective for patients with advanced gastric cancer. However,because of the severe hematological toxicity and gastrointestinal reaction caused by DCF regimen,its clinical application is still limited. This article reviewed the research progress of DCF regimen in treatment of advanced gastric cancer.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Gastroenterology
Año:
2017
Tipo del documento:
Article